Milestone Pharmaceuticals Inc.
Clinical trials sponsored by Milestone Pharmaceuticals Inc., explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- Nasal spray may offer quick fix for Children's racing heart Results expected Jun 2027 (estimated)
-
Nasal spray may offer quick fix for Children's racing heart
Disease control Recruiting nowThis study tests whether etripamil nasal spray can safely and quickly stop episodes of paroxysmal supraventricular tachycardia (PSVT) in children aged 6 to 17. PSVT causes sudden rapid heartbeats that can be frightening and require medical attention. The spray is designed to be u…
Phase 2 • Sponsor: Milestone Pharmaceuticals Inc. • Aim: Disease control
Last updated Jul 23, 2026 00:00 UTC
-
Nasal spray could tame racing heart in AFib patients
Symptom relief Recruiting nowThis study tests an investigational nasal spray called etripamil for people with atrial fibrillation (AFib) who experience episodes of dangerously fast heart rate. About 750 adults will be randomly assigned to use either the real spray or a placebo at home when symptoms start. Th…
Phase 3 • Sponsor: Milestone Pharmaceuticals Inc. • Aim: Symptom relief
Last updated Sep 11, 2026 00:00 UTC